In 2017, the opioid epidemic was declared a U.S. public health emergency. Opioid overdose deaths continued to rise through 2022, with over 81,000 deaths in 2022 alone.
To address the crisis, a multipronged approach consisting of evidence-based practices (EBPs) across prevention, harm reduction, and treatment is needed. EBPs for opioid use disorder include medications for opioid use disorder (MOUD) such as buprenorphine, methadone, and extended-release naltrexone, overdose education and naloxone distribution (OEND), and safer opioid prescribing. Understanding the scale of different EBPs needed to reduce opioid overdose deaths can inform resource planning.
Contact
Carolina Barbosa, PhD
RTI International
cbarbosa@rti.org
Acknowledgment
This work is supported through funding from the NIH HEAL Initiative under award number UM1DA049394.
This work is licensed under a Creative Commons Attribution-Non Commercial 4.0 International License
© MGH Institute for Technology Assessment & Baylor College of Medicine 2025